Patrick Griffith

EndoChoice, Inc. operates as a medtech company which focuses on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices, and infection control products and pathology services. Its imaging systems include fuse endoscopy system, fuse accesories, carts, cart options, monitors, monitor cart mounts, monito wall mounts, scope services, and suction pumps and supplies. Its devices include band ligators, biopsy forceps, bipolar probes, bite blocks, cytology brushes, electrosurgical supplies, metal stents, needles, retrieval devices, and snares. The company was founded by Mark G. Gilreath and William Parks in 2007 and is headquartered in Alpharetta, GA.

Elucid Bioimaging is a medical technology company based in the United States that aims to understand and treat the underlying cause of heart attacks and strokes, specifically subclinical atherosclerosis. The company is based in Boston, MA and was founded in 2009 by Andrew Buckler. The company uses AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease. Elucid Bioimaging's proprietary software, Vascucap, is the first tool to quantify atherosclerotic plaque against histology, deliver key arterial measures, and provide 3D visualization to inform the risk of events such as stroke or heart attack. Vascucap's unique information informs better treatment decisions by physicians, leading to better patient outcomes at a reduced cost of care. The CEO is Blake Richards.

Foldax, Inc. develops synthetic heart valves for delivering non-thrombogenic aortic and mitral valves. The company is headquartered in Salt Lake City, UT.

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

The Medical Device Manufacturers Association operates as a trade association. The private company is based in Washington. The American company was founded by Thomas C. Thompson.

Digma Medical Ltd. develops a device-based, one-time, non-invasive procedure, that restores the body’s natural ability to control glucose, which may provide long term remission from Type-2 Diabetes. The company was founded by Tamir Wolf and Irit Yaniv in 2013 and is headquartered in Petah Tikva, Israel.

Peloton Equity LLC (Peloton Equity) is a private equity firm founded in 2014 by Carlos Ferrer and Ted Lundberg. The firm is headquartered in Greenwich, Connecticut.

Verb Surgical, Inc. designs and manufactures surgical equipment. The company was founded in August 2015 and is headquartered in Santa Clara, CA.

VS, Inc. engages in the development of human-like surgical robotics. It creates virtual reality software for minimally invasive surgery procedures. The company was founded by Adam Sachs, Barry E. Greene and Sammy Khalifa in 2014 and is headquartered in Charlestown, MA.

Hyperfine Research, Inc. provides technology solutions. It designs and develops devices and software to improve healthcare. The company was founded by Jonathan Rothberg and Gregory Charvat in 2014 and is headquartered in Guilford, CT.

Curve Therapeutics Ltd. operates as a drug-discovery company. It engages on the development of innovative technologies to address undruggable disease-modifying targets, with an in-house focus on cancer. The company was founded in 2019 and is headquartered in London, the United Kingdom.

Proximie Ltd. is a health technology platform that focuses on digitizing operating and diagnostic rooms. The company is based in London, UK. The British company's mission is to provide quality surgical care globally by delivering a connected surgical platform. Proximie's platform allows for every procedure to be recorded, analyzed, and leveraged for future use to inform best practices. Proximie's ultimate ambition is to create a future network of operating rooms interconnected by the world's best clinicians, where every incision is already informed by machine learning and every clinician will be empowered with real-time diagnostics, data, and analysis. The company was founded in 2016 by Dr. Nadine Hachach-Haram and Talal Ali Ahmad. Dr. Nadine Hachach-Haram has been the CEO since 2016.

Kardion GmbH is a German company that manufactures and supplies medical technical instruments. The company is based in Stuttgart, Germany. The CEOs of the company are Hardy Baumbach, Inga Schellenberg.

Q'Apel Medical, Inc. designs novel access device technology for vascular interventions and unmet clinical needs. The company is based in Fremont, CA. The CEO of the company is R. King Nelson.

VIDA FLaSH Acquisitions operates as a development stage company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Frank Litvack and Scott R. Huennekens on January 29, 2021 and is headquartered in Los Angeles, CA.

AviadoBio Ltd. is a gene therapy company based in London, UK. AviadoBio's technology is based on pioneering research from King's College London and the UK Dementia Research Institute. The British company's mission is to develop and deliver transformative gene therapies for neurodegenerative disorders, including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company is developing AVB-101 for patients with FTD-GRN. AviadoBio's investors include New Enterprise Associates (NEA), Monograph Capital, Advent Life Sciences, EQT Lifesciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), and LifeArc. The company was founded by Youn Bok Lee, Do Young Lee, Chris E. Shaw, and Lisa Deschamps has been the CEO of the company since 2021.